U.S. Pharmaceuticals & Biotech Upcoming Dividends

Bristol-Myers Squibb

Market Cap: US$122.9b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Johnson & Johnson

Market Cap: US$564.0b

Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

Zoetis

Market Cap: US$51.5b

Engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.

Amgen

Market Cap: US$191.8b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

AbbVie

Market Cap: US$368.6b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Agilent Technologies

Market Cap: US$34.4b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Royalty Pharma

Market Cap: US$29.6b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Danaher

Market Cap: US$137.8b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.